Updated safety and clinical activity results from a phase Ib study of atezolizumab + bevacizumab in hepatocellular carcinoma (HCC)

Updated safety and clinical activity results from a phase Ib study of atezolizumab + bevacizumab in hepatocellular carcinoma (HCC)

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 29; pp. viii718 - viii719
Main Authors: Pishvaian, M.J., Lee, M.S., Ryoo, B.-Y., Stein, S., Lee, K.-H., Verret, W., Spahn, J., Shao, H., Liu, B., Iizuka, K., Hsu, C.-H.
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-10-2018
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy424.028